Oncodaily·3 min read·medium

Elabrar Ebrahim’s Clinical Trial Protocol Accepted for the AACR

L
Lusine Tadevosyan
Elabrar Ebrahim’s Clinical Trial Protocol Accepted for the AACR
AI Summary

Clinical oncology resident Elabrar Ebrahim shares her experience of having her clinical trial protocol accepted for a prestigious AACR-ASCO workshop. She highlights the importance of mentorship and the inclusion of researchers from low- and middle-income countries in global oncology discussions.

Elabrar Ebrahim , Resident clinical oncology at Alexandria University, shared on LinkedIn :

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealtheducation

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in

Elabrar Ebrahim’s Clinical Trial Protocol Accepted for the AACR — Headlinne — headlinne